Biosynex SA's total assets for Q4 2024 were €194.69M, a decrease of -6.74% from the previous quarter. FR:ALBIO total liabilities were €114.19M for the fiscal quarter, a 8.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.